The GENCOV study developed clinical laboratory‑based risk scores to predict mortality among hospitalized COVID‑19 patients in ...

A clinical trial led by Kirby Institute at UNSW Sydney has found that point-of-care testing for hepatitis B DNA is as effective as traditional laboratory testing, paving the way for faster diagnosis ...

Review & Outlook: CDC director Rochelle Walensky says she’s going to reshuffle the agency with an emphasis on 'action' and 'equity.' Her diagnosis and prescription are both wrong. Images: ...

Hims & Hers—the virtual care platform with about 2.5 million subscribers—will now offer laboratory testing through Quest Diagnostics. Customers will have access to more than 120 biomarker tests across ...

Spending on the tests, which analyze genetic material from both people and pathogens, rose 20% year over year in 2024, the ...